American International Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-38,976
| Closed | -$386K | – | 207 |
|
|
2024
Q1 | $386K | Sell |
38,976
-335
| -0.9% | -$3.32K | ﹤0.01% | 1784 |
|
|
2023
Q4 | $127K | Buy |
39,311
+13,651
| +53% | +$44.1K | ﹤0.01% | 2421 |
|
|
2023
Q3 | $136K | Buy |
25,660
+912
| +4% | +$4.84K | ﹤0.01% | 2338 |
|
|
2023
Q2 | $236K | Buy |
24,748
+4,716
| +24% | +$44.9K | ﹤0.01% | 2075 |
|
|
2023
Q1 | $220K | Buy |
20,032
+399
| +2% | +$4.39K | ﹤0.01% | 2061 |
|
|
2022
Q4 | $291K | Buy |
19,633
+233
| +1% | +$3.45K | ﹤0.01% | 1917 |
|
|
2022
Q3 | $371K | Buy |
19,400
+3,006
| +18% | +$57.5K | ﹤0.01% | 1766 |
|
|
2022
Q2 | $349K | Buy |
16,394
+2,661
| +19% | +$56.6K | ﹤0.01% | 1826 |
|
|
2022
Q1 | $264K | Sell |
13,733
-967
| -7% | -$18.6K | ﹤0.01% | 2080 |
|
|
2021
Q4 | $305K | Sell |
14,700
-439
| -3% | -$9.11K | ﹤0.01% | 2110 |
|
|
2021
Q3 | $362K | Sell |
15,139
-360
| -2% | -$8.61K | ﹤0.01% | 2059 |
|
|
2021
Q2 | $423 | Buy |
15,499
+2,028
| +15% | +$55 | ﹤0.01% | 2030 |
|
|
2021
Q1 | $390 | Buy |
13,471
+1,433
| +12% | +$41 | ﹤0.01% | 1965 |
|
|
2020
Q4 | $339 | Buy |
12,038
+1,228
| +11% | +$35 | ﹤0.01% | 1983 |
|
|
2020
Q3 | $317K | Buy |
10,810
+5,013
| +86% | +$147K | ﹤0.01% | 1840 |
|
|
2020
Q2 | $175K | Sell |
5,797
-362
| -6% | -$10.9K | ﹤0.01% | 2198 |
|
|
2020
Q1 | $184K | Buy |
+6,159
| New | +$184K | ﹤0.01% | 1946 |
|